GSK Trades At Low Price Multiples, But Its Pipeline Needs To Improve [Seeking Alpha]
12 Best Biotech Penny Stocks to Invest In [Yahoo! Finance]
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
GSK plc (NYSE: GSK) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating.